Endocannabinoids are lipidic modulators able to bind cannabinoid receptors (CNRs). Two types of CNRs have been cloned, CNR1 (central) and CNR2 (peripheral). The objectives of the present study were to investigate the expression pattern of CNR1 in the rat testis during prepubertal development and to define the CNR1 spatiotemporal pattern. From 31 to 60 days of age, CNR1 was immunolocalized in round elongating spermatids and spermatozoa, suggesting an important role for this receptor in spermatogenesis. From 14 to 60 days of age, adult Leydig cells (ALCs) at different developmental stages were positive for CNR1. In particular, CNR1 expression in differentiating ALCs was negatively correlated to cell division. Bromodeoxyuridine uptake experiments on serial sections showed that immature Leydig cells in mitosis were negative for CNR1; in contrast, immature nonmitotic Leydig cells were positive for CNR1. A further observation of few ALCs in CNR1KO mice validates the role of CNR1 during proliferative activity involved in ALC differentiation. In addition, starting from 41 days of age, a faint CNR1 signal was also observed in Sertoli cells. Taken together, these results demonstrate the first clear evidence (to our knowledge) of CNR1 in mammalian germinal epithelium, ALCs, and Sertoli cells and indicate that differentiation of ALCs may depend on the endocannabinoid system.
INTRODUCTION
Cannabinoid receptors (CNRs) bind a class of lipid mediators, the endocannabinoids, that is involved in several physiological processes (e.g., food intake, memory, energy balance, immune system, and reproduction) [1] [2] [3] . In the past few decades, the increasing recreational use of cannabinoids such as marijuana and the potential negative health effects have reinforced public concern about these compounds. Cannabinoid research received an initial boost from the characterization of D 9 -tetrahydrocannabinol, the primary psychoactive cannabinoid in marijuana (Cannabis sativa) [4] . This was followed many years later by the cloning of type-1 and type-2 CNRs (CNR1 and CNR2, respectively) [5, 6] and by the identification of their endogenous ligands, the endocannabinoids.
Cannabinoid receptors are members of the superfamily of seven transmembrane-spanning (7-TM) receptors, having a protein structure defined by an array of seven membranespanning helices with intervening intracellular domains that can associate with G i -G o proteins [7] . CNR1 is expressed primarily in the central nervous system and to a lesser extent in several peripheral tissues, including the testis; in contrast, CNR2 is distributed predominantly in immune cells [7] .
All endocannabinoids are structurally distinct from plantderived compounds and synthetic cannabinoids. They are amides, esters, and ethers of long-chain polyunsaturated fatty acids and are able to bind both CNRs, although with different affinities and efficacies [8] . Furthermore, they are able to produce some of the peripheral and central effects of tetrahydrocannabinol [9] . To date, two main endocannabinoids have been described, arachidonoyletanolamide (AEA) [10] and 2-arachidonoylglycerol (2-AG) [11] . They are released enzymatically on demand from membrane phospholipids when cells are stimulated by depolarizing agents, neurotransmitters, and hormones [12] . Endocannabinoid signaling is efficiently limited by a two-step degradation process involving facilitated uptake from the extracellular space and intracellular catabolism mediated by specific enzymes. Cannabinoid receptors, endocannabinoids, and the machinery for their synthesis and degradation represent the elements of a novel endogenous signaling system (the endocannabinoid system) involved in a plethora of physiological functions [3] .
In different species, CNRs have been found in testis [13] [14] [15] and isolated spermatozoa [16] [17] [18] . In testis, CNR1 has been observed in Leydig cells [14] and in several spermatogenic stages [15] , as well as in the seminiferous epithelium of the amphibian frog Rana esculenta [17, 19] .
In man and rodents, chronic exposure to or use of cannabinoids decreases testosterone production and secretion by Leydig cells [20, 21] , depresses spermatogenesis [22] , and reduces the weight of testes and accessory reproductive organs [23] (see review by Wang et al. [24] ). The association between AEA (anandamide) injection and reduction in luteinizing hormone and testosterone levels in CD1 wild-type (WT) mice but not in CNR1 knockout (CNR1KO) mice confirms the importance of the adverse effects of cannabinoids on the testis [14] . The findings that male genital tract fluids contain endocannabinoids [25] and that the rat testis is able to synthesize AEA [26] suggest that these lipid-signaling molecules could play a role in sperm or egg interactions and in testicular activity. Evidence in sea urchin gametes demonstrates that AEA is able to directly inhibit the acrosome reaction and sperm-fertilizing ability [27] . In the frog R. esculenta, AEA reduces the percentage of motile spermatozoa via CNR1 [17] . In humans, CNR1 activation by AEA reduces sperm motility [16] and in boars inhibits acrosome reaction [18] .
Taken together, these results suggest a central role for endocannabinoids in the regulation of testosterone production and spermatogenesis. Furthermore, a spatiotemporal difference in CNR1 expression during postnatal development in the mouse testis has been described [15] . However, the exact role of CNRs in rat Leydig and germ cell proliferation, development, or function, specifically during the postnatal period, has not been elucidated so far, to our knowledge. The aim of the present study was to investigate the expression pattern of CNR1 in the rat testis during prepubertal development, with particular emphasis on adult Leydig cell (ALC) generation, which requires proliferation events underlying differentiation.
MATERIALS AND METHODS

Experimental Animals
Sprague-Dawley rats (Rattus norvegicus) from our colony were housed in the Biotechnology Center A.O.R.N. Cardarelli (Naples, Italy) and were maintained on a standard pellet diet with free access to water. Males were killed at Postnatal Day 7, 14, 21, 31, 35, 41, 60, or 90 , and the testes were rapidly removed. One testis per animal was frozen on dry ice for subsequent Western blot and RT-PCR analyses, whereas the contralateral testis was fixed for immunohistochemistry. CD1 WT and CNR1KO (official symbol, Cnr1 tm1Map ) mice (Mus musculus) (Charles River) [28] were killed at Postnatal Day 33 or 60. Testes were fixed in Bouins fluid according to standard procedures and were stained using hematoxylin-eosin. At least three animals were analyzed at each age. Experiments were approved by the Italian Ministry of Education and the Italian Ministry of Health. Procedures involving animal care were conducted in accord with the Guide for Care and Use of Laboratory Animals (National Institutes of Health guide) by the National Research Council.
Tissue Protein Preparation
Tissues (brain or testis) were homogenized in extraction buffer (20 mM Tris-HCl, pH 7.5, 0.5 mM EGTA, 2 mM EDTA, 1 mM dithiothreitol [DTT] ) in the presence of protease inhibitors (120 lg/ml of leupeptin, aprotinin, pepstatin A, and chymostatin and 5 lg/ml of TPCK [l-1-tosylamide-2-phenylethyl chloromethyl ketone-trypsin]). The homogenates were sonicated on ice (twice for 20 sec at 40 kHz) and were centrifuged for 15 min at 800 3 g to remove nuclei. A further centrifugation was carried out at 100 000 3 g for 30 min at 48C, and the supernatants (cytosol fraction) were collected. The pellets (membrane fraction) were resuspended in extraction buffer containing 0.3% Triton X-100 (w/w), left on ice for 60 min, and centrifuged again at 100 000 3 g for 60 min. The resulting supernatants (solubilized membrane fraction) were collected and stored at À808C [29] . Protein concentration was determined using the method by Lowry et al. [30] .
Antibodies
For Western blot analysis, we used a polyclonal antibody directed against the N-terminal (first 77 residues) of rat CNR1 [31] . For immunohistochemistry, we used a polyclonal antibody directed against the N-terminal domain (first 100 residues) of human CNR1 [32] . Specificity of these antibodies has been investigated extensively in several species [32] [33] [34] [35] and was confirmed in the present studies by preadsorption with an excess amount (2 lg) of the cognate peptide.
Anti-ERK1 (sc-154; Santa Cruz Biotechnology Inc.) was commercially obtained. Anti-type I 3b-hydroxysteroid dehydrogenase HSD3B (3b-HSD) antibody, raised in rabbit, was kindly provided by Prof. J.I. Mason (University of Edinburgh, Edinburgh, United Kingdom).
Western Blot Analysis
Proteins were separated using 9% SDS-polyacrylamide gel electrophoresis and transferred to polyvinylidene fluoride filters (GE Healthcare) at 280 mA for 2.5 h at 48C to evaluate CNR1 immunoreactivity. To prevent nonspecific binding, filters were treated for 2.5 h with blocking solution (5% nonfat powdered milk, 0.25% polyoxyethylene sorbitan monolaurate (Tween 20) in Tris-buffered 130 saline [TBS], pH 7.6) and then incubated with the primary antibody (anti-rat N-terminal CNR1 diluted 1:1000) in TBS containing 3% nonfat powdered milk solution overnight at 48C on an orbital shaker. Filters, washed in TBS-0.25% Tween 20, were incubated with 1:1000 horseradish peroxidase-conjugated IgG (DAKO Corp.) in TBS-1% normal swine serum (DAKO Corp.) and then washed three times in TBS-0.25% Tween 20. The immune complexes were detected using the ECL Western blotting detection system (GE Healthcare), following the manufacturer's instructions. Specificity of the reactions was tested through competition studies using the antibody previously preabsorbed for 18 h at 48C on an orbital shaker with a large excess (2 lg) of the corresponding antigen. The membranes, stripped at 608C for 30 min in stripping buffer (100 mM 2-mercaptoetanol, 2% SDS, 62.5 mM TrisHCl, pH 7.6), were reprobed with MAPK3 (also known as ERK1) antibody to quantify protein content. MAPK3 levels did not change in rat testis during prepubertal development [36] .
Immunohistochemistry
Testes were fixed overnight in Bouins fluid and were embedded in paraffin using standard procedures. Microtome sections (5 lm thick) were incubated overnight with one of the following primary antibodies: rabbit anti-human Nterminal CNR1 (dilution 1:500 in 0.01 M PBS, 1% Triton X-100, 10% BSA) or rabbit anti-3bHSD (dilution 1:1000 in 0.01 M PBS, 1% Triton X-100). Immunoreactivity was revealed using the avidin-biotin complex system and H 2 O 2 /DAB (3,3
0 -diaminobenzidine-tetrahydrochloride) as substrate and chromogen. To check the specificity of the immunoreactions, some sections were treated with antibodies preabsorbed for 18 h at 48C on an orbital shaker with a large excess (2 lg) of the corresponding antigen. Furthermore, specificity was confirmed by omitting the primary antibody. Sections were observed under a light microscope (CTR500; Leica), and images were captured using a highresolution digital camera (DC300F; Leica).
Immunofluorescent Analysis of Spermatozoa
Rat sperm, collected from the epididymis, were dried on slides coated with poly-L-lysine, postfixed in 4% paraformaldeide in PBS for 5 min at 48C, and washed 3 times for 5 min in PBS. Nonspecific binding was limited by incubation of slices in PBS with 1% normal swine serum and 1% Triton X-100 for 20 min at room temperature. Slides were then incubated with primary antibody, rabbit antihuman N-terminal CNR1, and diluted 1:300 in PBS-0.1% Triton X-100 overnight at room temperature. Slides were then washed in PBS as already described before incubation with secondary antibody rhodamine-conjugated antirabbit (Chemicon, Prodotti Gianni) diluted 1:100 in PBS-1% Triton X-100-1% goat serum for 1 h at room temperature. After washing, slides were incubated with 300 nM DAPI (4 0 ,6 0 -diamidino-2-phenylindole) (Molecular Probes) for 2.5 min and sealed with 1 drop of slowfade light antifade (S-7461; Molecular Probes).
Specificity of immunosignal was tested by preadsorbing antibody with an excess of the corresponding antigen (2 lg). Slides were evaluated and images captured using a laser scanning TCS SP1/MP confocal microscope (Leica).
Total RNA Preparation
Total RNA was extracted from rat and mice testes using Trizol reagent (Invitrogen Life Technologies). In brief, the sample was homogenized in Trizol Reagent (1 ml of Trizol reagent per 50-100 mg of tissue); after homogenization, the sample was incubated for 5 min at room temperature to permit the complete dissociation of nucleoprotein complexes. Then 0.2 ml of chloroform/ml of Trizol reagent was added and the sample centrifuged at 12 000 3 g for 15 min at 48C. The aqueous phase was transferred to a fresh tube, and tRNA was precipitated by mixing with isopropyl alcohol (0.5 ml/ml of Trizol reagent). After centrifugation at 12 000 3 g for 10 min at 48C, the RNA pellet was washed with 75% ethanol, centrifuged at 7500 3 g for 5 min at 48C, and dissolved in an appropriate volume of diethyl carbopyronate-treated water. Total RNA purity and integrity were determined by spectrophotometry at 260/280 nm and by electrophoresis.
Messenger RNA Detection by RT-PCR
Total RNA was reverse transcribed to prepare cDNA. The reverse transcription was performed using 2 lg of tRNA, 0.5 lg of oligo dT, 10 mM deoxyribonucleotide triphosphate (dNTP), 0.01 M DTT, 13 first-strand buffer (Invitrogen Life Technologies), 40 U of RNase Out (Invitrogen Life Technologies), and 200 U of SuperScript-III RNaseH À RT (Invitrogen Life Technologies) in a final volume of 20 ll, following the manufacturer's instructions. As a negative control, tRNA not treated with RT was used.
TYPE-1 CANNABINOID RECEPTOR IN RAT TESTIS
For rat testes, the PCR reaction was performed using 2 ll of cDNA and 10 pmol of oligonucleotide primers specific for the amino-terminal domain of rat Cnr1 0 ; amplificon predicted size, 191 bp) in the same PCR mix already described. The PCR conditions were as follows: 948C for 5 min, 1 cycle; 948C for 1 min, 608C for 1 min, 728C for 1 min, 35 cycles; and 728C for 5 min, 1 cycle. To normalize the signals, 2 ll of rat cDNA or 1 ll of mouse cDNA was mixed with 10 pmol of specific primers for rat and mouse Actn (actin) (sense 5 0 -CTCTTCCAGCCTTCCTTCCT-3 0 ; antisense 5 0 -CTGCTTGCTGATCCA-CATC-3 0 ; amplificon predicted size, 298 bp) with the previously described PCR mix. The PCR conditions were as follows: 948C for 5 min, 1 cycle; 948C for 1 min, 568C for 1 min, 728C for 1 min, 25 cycles; and 728C for 5 min, 1 cycle. Possible contaminations among samples were evaluated using negative control samples prepared without cDNA. Finally, 25 ll of PCR amplification mixtures were analyzed by electrophoresis on 1.3% agarose gel in 13 Tris-acetate buffer and stained with 0.5 lg/ml of ethidium bromide.
Bromodeoxyuridine DNA Labeling
Thirty-four-and 40-day-old Sprague Dawley rats were injected with 100 mg/kg of bromodeoxyuridine (BrdU) (GE Healthcare) and killed 24 hours later. Testes were immediately dissected, fixed in Bouins fluid, and embedded in paraffin. Hydrated sections (2.5 lm thick) were further processed for immunohistochemistry using an immunoperoxidase staining kit (GE Healthcare), as recommended by the manufacturer. Negative controls were processed in the same way except that the primary antibody was omitted and PBS substituted.
Cells immunopositive for (BrdU)/(HSD3B) or for (CNR1)/(HSD3B) were counted per optical field and were expressed as the number of positive cells per square millimeter. For each slide, a minimum of 30 random fields was selected, and a minimum of 10 random sections per testis was evaluated.
Leydig Cells Count in CNR1KO Mice Testes
Leydig (HSD3B immunopositive) cells were quantified in the interstitium of WT and CNR1KO mice testis at Postnatal Days 33 and 60. HSD3B-positive cells were counted per optical field and were expressed as the number of positive cells per square millimeter. For each slide, a minimum of 30 random fields were selected, and a minimum of 10 random sections per testis were evaluated.
Data Presentation and Statistics
Western blot and PCR signals were quantified by densitometry analysis performed using the GELDOC1,00-UV system (BioRad Laboratories). Cnr1 mRNA and protein levels were plotted as quantitative densitometric analyses of signals and were expressed relative to Actn mRNA and MAPK3 protein content, respectively. Values were expressed as optical density (OD) units.
Student t-test and ANOVA, followed by Duncan test for multigroup comparison, were performed where appropriate to evaluate the significance of differences. Data were expressed as the mean 6 SEM from at least three independent experiments.
RESULTS
Western Blot Analysis of CNR1 in Rat Tissues
The presence of CNR1 protein was checked in testes, while brain was used as a positive control (Fig. 1) . A band with the expected weight of 66 kDa was evident in the membrane and cytosol fractions (Fig. 1A) . The use of the preabsorbed 
FIG. 1. Western blot analysis of CNR1 in rat brain and testis. A) Protein extracts from membrane and cytosol fractions (70 lg/lane)
were analyzed using rat anti-CNR1 N-terminal antibody (Ab). B) The specificity of reaction was checked by preabsorbing the antibody with a large excess (2 lg) of the corresponding peptide. Results are representative of three separate protein preparations.
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antiserum failed to detect the signals, demonstrating specificity of the reaction in both samples (Fig. 1B) .
Immunohistochemical Analysis of Adult Rat Testes
Immunohistochemistry demonstrated a clear and strong immunopositivity for CNR1 (Fig. 2) in the tubular and interstitial compartments. In round spermatids, CNR1 was present around the nucleus, where the acrosome is forming ( Fig. 2A, inset) . In elongating spermatids, CNR1 was localized near the acrosome (Fig. 2B, inset) . Moreover, in stages VI/VII-IX/X, a faint CNR1 signal was also observed in Sertoli cells (Fig. 2, A and C) . In interstitial compartments, CNR1 was evident in Leydig cells (Fig. 2C) . No immunopositivity was detected in testicular sections using preabsorbed antibody as a control (Fig. 2D) .
Immunofluorescent Analysis of Rat Spermatozoa
Strong immunoreactivity for CNR1 (Fig. 3) was localized along the head and tail of sperm (Fig. 3A) . In the head, confocal analysis showed CNR1 primarily where the acrosome was present. Specificity of the immunostaining was confirmed by the use of preadsorbed antibody (Fig. 3B) .
RT-PCR Analysis of Prepubertal Rat Testes
During rat postnatal development, fluctuations in Cnr1 mRNA expression were observed in testes from Postnatal Days 7 to 90 (Fig. 4A) . The Cnr1 levels were notably high at Postnatal Days 7, 35, 60, and 90 (P , 0.01). At Postnatal Day 41, Cnr1 expression decreased (P , 0.01) but was higher compared with that at Postnatal Days 14 (P , 0.01), 21 (P , 0.01), and 31 (P , 0.05) (Fig. 4B) .
The PCR analysis on tRNA untreated with RT did not show any signal. Similar results were obtained when using primers pairs for the carboxy-terminal domain of rat Cnr1 (data not shown).
Immunohistochemical Analysis of Prepubertal Rat Testes
Similar to the RT-PCR analysis, testes were analyzed from Postnatal Day 7 onward (Fig. 5) . CNR1 signal appeared from Postnatal Days 14 to 21 in interstitial cells (Fig. 5, B and C) , while at the same time points there was no immunopositivity for CNR1 in germ cells. Interstitial cells at Postnatal Days 14 and 21 were spindle shaped and positive for CNR1.
At Postnatal Days 31 and 35, round spermatids and roundshaped interstitial cells were positive for CNR1 (Fig. 5, D and E). At this stage, spermatids showed a polarized signal around the nucleus. In 41-day-old testes, CNR1 was localized in elongating spermatids and Sertoli cells and in roundshaped interstitial cells (Fig. 5F ). Testes from 60-day-old male rats showed the same immunostaining for CNR1 as that observed in adult testes in elongating spermatids and in interstitial cells. The latter seemed to be predominantly or exclusively in Leydig cells based on the detection of HSD3B in CNR1-immunopositive interstitial cells at Postnatal Day 14 (spindle shaped) and at Postnatal Day 31 (round shaped) (Fig. 6) . 
TYPE-1 CANNABINOID RECEPTOR IN RAT TESTIS
Western blot analysis demonstrated that CNR1 protein was present in testes at Postnatal Days 35 and 41 ( Fig. 7A) . At Postnatal Day 41, quantitative densitometric analysis of signals indicated a significantly lower expression of CNR1 compared with that at Postnatal Day 35 (P , 0.05) (Fig. 7B) . Fewer CNR1-immunopositive Leydig (HSD3B immunopositive) cells were found at Postnatal Day 41 vs. at Postnatal Day 35 (P , 0.01) (Fig. 8) .
BrdU DNA Labeling
To determine if low levels of Cnr1 mRNA and protein at Postnatal Day 41 were related to the increased mitosis of Leydig cells [37] , the mitotic index was determined using BrdU labeling at Postnatal Days 35 and 41. A significantly higher number of BrdU-labeled Leydig cells was observed in testes at Postnatal Day 41 compared with that at Postnatal Day 35 (P , 0.01) (Fig. 9) . To further confirm that BrdU-labeled Leydig cells from 41-day-old testes were not expressing CNR1, an immunohistochemical analysis was performed on serial sections from 35-and 41-day-old testes with the following three primary antibodies: HSD3B to recognize Leydig cells, BrdU to identify mitotic cells, and CNR1. As shown in Figure 10 , at Postnatal Day 41 immature Leydig cells (HSD3B immunopositive) comprised the following two populations: 1) proliferating BrdU-positive cells that were CNR1 negative and 2) nonproliferating BrdU-negative cells that were CNR1 positive. Indeed, BrdU-positive Leydig cells (Fig. 10B) were not detected by the CNR1 antiserum (Fig.  10C ) but were unequivocally stained by the HSD3B antiserum (Fig. 10A) , together with BrdU-negative Leydig cells.
CNR1KO Mice Testes
As expected in WT and CNR1KO mice, the number of Leydig cells increased from Postnatal Days 33 to 60 (P , 0.01). Significantly fewer HSD3B-positive cells were observed in testes of 33-and 60-day-old CNR1KO mice compared with WT mice (P , 0.01) (Fig. 11A) . Conversely, in the seminiferous tubules at Postnatal Day 40, all differentiation stages of male germ cells (from spermatogonia to mature spermatids) were observed in WT mice (Fig. 11B ) and in CNR1KO mice (Fig. 11C) . Moreover, Kit mRNA expression was similar in testes from WT mice and from CNR1KO mice (Fig. 11D ).
DISCUSSION
In this study using morphologic and molecular approaches, we demonstrated that CNR1 is present in tubular and interstitial compartments of the testis of prepubertal and adult rats. Furthermore, we provided evidence for CNR1 involvement in the differentiation of ALCs.
By Western blot analysis, we evaluated the presence of CNR1 in rat testis. The expected signal was found in membrane and cytosol fractions. Moreover, immunohistochemical analysis showed this protein in certain germ cells (from round spermatids to spermatozoa), in Sertoli cells, and in ALCs. In germ cells, CNR1 was localized in round spermatids around the nucleus, where the acrosome is forming. The signal was maintained in elongating spermatids and in the head area, always near the acrosome region. A faint CNR1 signal was observed in Sertoli cells, particularly in stages VI-X of spermatogenesis. We cannot exclude the presence of CNR1 in Sertoli cells supporting other stages of spermatogenesis. In fact, the strong immunoreaction evidenced in spermatids during their elongation may mask a putative faint signal in Sertoli cells. As far as we are aware, this is the first clear evidence of CNR1 presence in Sertoli cells. Our results further indicate that CNR1 is expressed in Leydig cells [14] . Contrary to data reported by Gye and coworkers [15] showing CNR1 in nuclear compartments of spermatogonia and spermatocytes, the immunolocalization described herein better correlates with CNR1 performance, generally accepted as 7-TM receptor activity. Furthermore, our confocal analysis of CNR1 on spermatozoa collected from the epididymis confirms previous results in humans [16] and localizes the protein in the head and tail. In particular, we show that CNR1 is present along the head close to the acrosome. It is possible that this intracellular distribution is species specific, as CNR1 in boar spermatozoa CNR1 is reported to be expressed in the postacrosomal region [18] . Because CNR1 presence during spermatogenesis has also been demonstrated in a lower vertebrate, the R. esculenta frog [17] , this suggests an evolutionarily conserved role of endocannabinoids in the morphogenesis and physiology of spermatozoa. Similarly, marijuana smokers show morphological alterations in their spermatozoa [38, 39] , and cannabinoid exposure in rodents induces aberrations in sperm morphology [40] . Finally, recent results show that AEA decreases sperm TYPE-1 CANNABINOID RECEPTOR IN RAT TESTIS motility in humans and frogs [16, 17] and reduces spermfertilizing ability by blocking the acrosome reaction in sea urchins [27] .
To address the temporal pattern of CNR1 expression in germ cells, we evaluated mRNA and protein expressions during development from Postnatal Days 7 to 90. At Postnatal Day 7, high Cnr1 expression was observed. From Postnatal Days 14 to 31, mRNA decreased to low levels, but at Postnatal Day 35 it increased significantly, coincident with the first appearance of round spermatids in the seminiferous epithelium. At Postnatal Day 41, a significant decrease in Cnr1 expression was observed, followed by a further increase from Postnatal Days 60 to 90. These age-dependent variations in Cnr1 expression are most likely explained by factors such as the increase in ALC numbers, coupled with the appearance of Cnr1-expressing germ cells (spermatids) in the seminiferous epithelium.
Immunohistochemical analysis demonstrated CNR1 in tubular and interstitial compartments. Investigation of whether or the same ligand (AEA or 2-AG) activates CNR1 signaling in tubular and interstitial compartments should be pursued further. However, as far as CNR1 localization is concerned, in the tubular compartment starting at Postnatal Day 31, CNR1 appeared in round spermatids. At Postnatal Days 35 and 41, the protein was evident in elongating spermatids at their early and late phases of maturation. With respect to Sertoli cells, CNR1 appeared at 41 days and the signal was maintained until adulthood. Contrarily to adulthood, Sertoli cells supporting elongating spermatids showed a clear CNR1 immunoreactivity. This may be due to the low number of elongating spermatids, immunopositive for CNR1 and present at Postnatal Day 41, not able to mask the signal in Sertoli cells. Sertoli cells are somatic cells able to protect, nourish, and support germ cells, and they show regional specializations according to the germ cell types specifically associated with them [41] . In mice, isolated Sertoli cells at Postnatal Days 4-16 do not express CNR1 [13] . Therefore, apart from species differences, our results may also be explained by a possible induction of CNR1 expression in Sertoli cells by germinal cell contact. As far as germinal cells are concerned, starting at Postnatal Day 31 CNR1 was expressed in round spermatids. At Postnatal Days 35 and 41, CNR1 protein was evident in elongating spermatids.
In the interstitial compartment, CNR1 appeared at an earlier age than in germ cells. From Postnatal Day 14 onward, we found CNR1 in spindle-shaped interstitial cells. This might imply a role for CNR1 in the generation of ALCs, which develop from stem Leydig cells (spindleshaped interstitial mesenchymal cells) through several steps of proliferation and differentiation during prepuberty [37] . By Postnatal Day 11 or 12, the spindle-shaped undifferentiated cells are committed to become ALCs by transforming into Leydig progenitor cells, still characterized by a spindle shape [42] . By Postnatal Day 28, the progenitor Leydig cells transform into round-shaped cells, characterized by numerous lipid droplets and abundant smooth endoplasmic reticulum, and these are immature Leydig cells [42] . To establish if the interstitial cells immunopositive for CNR1 belonged to the ALC lineage during postnatal development, we undertook an immunohistochemical analysis on serial testis sections. This showed that at Postnatal Day 14 (progenitor Leydig cells) and at Postnatal Day 31 (immature Leydig cells), interstitial cells were immunopositive for HSD3B [43] and CNR1. Immature Leydig cells divide once between Postnatal Days 28 and 56 before differentiation into ALCs [42] . This occurs at around Postnatal Day 41 [37, 44] , and at this age we observed that CNR1 levels were lower than those at Postnatal Day 35, in accord with the PCR results. The mitotic index of HSD3B-positive interstitial cells increased at this age. At the same age, immunohistochemical analysis on serial sections demonstrated that immature mitotic Leydig cells (BrdU and HSD3B positive) did not immunoexpress CNR1, while immature nonmitotic Leydig cells (BrdU negative and HSD3B positive) were immunopositive for CNR1. Therefore, our data suggest that CNR1 may be negatively involved in ALC proliferation at this stage. To pursue these results further, we used the CNR1KO mouse model. Mouse Leydig cells express CNR1 [14] ; therefore, to give insight into the possible involvement of endocannabinoids in ALC proliferation, we counted ALCs in CNR1KO and WT mouse testes. We showed that the number of ALCs in CNR1KO mice was lower than that in WT mice at Postnatal Days 33 and 60. Morphological and molecular analysis indicated that the absence of CNR1 specifically affected Leydig cells. Indeed, mature spermatids appeared at the same time in WT and CNR1KO animals. Furthermore, quantification of Kit mRNA as a marker of spermatogonial proliferation [45] did not show any difference between WT and CNR1KO mice. Together, these findings indicate that the absence of CNR1 primarily affects ALC number. Of note is that 33-day-old mice correspond to 41-day-old rats [46] . Therefore, CNR1KO mice developed few ALCs, and this further supports the theory of CNR1 involvement in ALC proliferation. The presence of few ALCs may explain the lower in vitro basal testosterone secretion in CNR1KO testes compared with WT testes [14] . Why a deficiency of CNR1 promotes the development of few ALCs while CNR1 is localized in immature nonmitotic Leydig cells should be further investigated.
